HR+ Breast Cancer: 2022 Year in Review : Episode 5
Additional Perspectives on Treatment Selection and Sequencing in Metastatic Breast Cancer
Dr Kaklamani and Dr McArthur share their experiences with CDK4/6 inhibitors and discuss how new data may change their approaches to sequencing treatments in the clinic.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Recent Videos
Related Content
